Xinyue Chen

State Key Laboratory Of Cardiovascular Disease, 167A Beilishi Road
Beijing, 100037, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications

Impact of a comprehensive healthy lifestyle score on a broad spectrum of cardiometabolic and related diseases and its incremental value for risk prediction based on the UK biobank database.

Impact of a comprehensive healthy lifestyle score on a broad spectrum of cardiometabolic and related diseases and its incremental value for risk prediction based on the UK biobank database.

Journal: Journal of cardiothoracic surgery
Published: March 05, 2026

Erratum/Corrigendum to "Cerebellar GluN2C protects against sleep deprivation-induced cognitive impairment and motor incoordination" [Sleep Med 137 (2025) 108648].

Erratum/Corrigendum to "Cerebellar GluN2C protects against sleep deprivation-induced cognitive impairment and motor incoordination" [Sleep Med 137 (2025) 108648].

Journal: Sleep medicine
Published: December 02, 2025

Elebsiran and PEG-IFNα for chronic hepatitis B infection: a partially randomized, open-label, phase 2 trial.

Elebsiran and PEG-IFNα for chronic hepatitis B infection: a partially randomized, open-label, phase 2 trial.

Journal: Nature medicine
Published: September 02, 2025

Inhibition of astrocytic AT1R ameliorates sleep deprivation induced Aβ deposition and glymphatic dysfunction via the MAPK/Cx43 pathway.

Inhibition of astrocytic AT1R ameliorates sleep deprivation induced Aβ deposition and glymphatic dysfunction via the MAPK/Cx43 pathway.

Journal: Sleep medicine
Published: June 22, 2025

Adding pegylated interferon-α to nucleos(t)ide analogs improves HBsAg clearance in chronic hepatitis B with low-level viremia.

Adding pegylated interferon-α to nucleos(t)ide analogs improves HBsAg clearance in chronic hepatitis B with low-level viremia.

Journal: Frontiers in medicine
Published: June 07, 2025

Cerebellar GluN2C protects against sleep deprivation-induced cognitive impairment and motor incoordination.

Cerebellar GluN2C protects against sleep deprivation-induced cognitive impairment and motor incoordination.

Journal: Sleep medicine
Published: May 14, 2025

Nitrate ameliorates myelin loss and cognitive impairment in Alzheimer's disease through upregulation of neuronal sialin and subsequent inhibition of TPPP phosphorylation.

Nitrate ameliorates myelin loss and cognitive impairment in Alzheimer's disease through upregulation of neuronal sialin and subsequent inhibition of TPPP phosphorylation.

Journal: Science bulletin
Published: November 27, 2024

Astrocytic GluN2A alleviates sleep deprivation-induced elevation of Aβ through regulating neprilysin and AQP4 via the calcineurin/NFAT pathway.

Astrocytic GluN2A alleviates sleep deprivation-induced elevation of Aβ through regulating neprilysin and AQP4 via the calcineurin/NFAT pathway.

Journal: Progress in neurobiology
Published: May 14, 2024

The potential serum sphingolipid biomarkers for distinguishing Wilson disease.

The potential serum sphingolipid biomarkers for distinguishing Wilson disease.

Journal: Clinica chimica acta; international journal of clinical chemistry
Published: November 19, 2023

Astrocytic AT1R deficiency ameliorates Aβ-induced cognitive deficits and synaptotoxicity through β-arrestin2 signaling.

Astrocytic AT1R deficiency ameliorates Aβ-induced cognitive deficits and synaptotoxicity through β-arrestin2 signaling.

Journal: Progress in neurobiology
Published: May 14, 2023

Serum HBsAg and HBcrAg is associated with inflammation in HBeAg-positive chronic hepatitis B patients.

Serum HBsAg and HBcrAg is associated with inflammation in HBeAg-positive chronic hepatitis B patients.

Journal: Frontiers in cellular and infection microbiology
Published: October 29, 2022

Serum HBV RNA is associated with liver fibrosis regression in HBeAg-positive chronic hepatitis B patients treated with nucleos(t)ide analogues.

Serum HBV RNA is associated with liver fibrosis regression in HBeAg-positive chronic hepatitis B patients treated with nucleos(t)ide analogues.

Journal: Journal of viral hepatitis
Published: September 21, 2022
Showing 1-12 of 26

Last Updated: 09/26/2026